BibTex format
@article{Abraham:2019:10.1016/S1473-3099(19)30279-8,
author = {Abraham, S and Juel, HB and Bang, P and Cheeseman, HM and Dohn, RB and Cole, T and Kristiansen, MP and Korsholm, KS and Lewis, D and Olsen, AW and McFarlane, LR and Day, S and Knudsen, S and Moen, K and Ruhwald, M and Kromann, I and Andersen, P and Shattock, RJ and Follmann, F},
doi = {10.1016/S1473-3099(19)30279-8},
journal = {Lancet Infectious Diseases},
pages = {1091--1100},
title = {Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial},
url = {http://dx.doi.org/10.1016/S1473-3099(19)30279-8},
volume = {19},
year = {2019}
}